Isoprostanes and isofurans as non-traditional risk factors for cardiovascular disease among Canadian Inuit

被引:12
|
作者
Alkazemi, Dalal [1 ,2 ]
Egeland, Grace M. [3 ,4 ]
Roberts, Lyman Jackson, II [5 ,6 ]
Kubow, Stan [1 ,2 ]
机构
[1] McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ H9X 3V9, Canada
[2] McGill Univ, Ctr Indigenous Peoples Nutr & Environm, Ste Anne De Bellevue, PQ H9X 3V9, Canada
[3] Univ Bergen, Norwegian Inst Publ Hlth, Bergen, Norway
[4] Univ Bergen, Fac Med & Dent, Bergen, Norway
[5] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA
[6] Vanderbilt Univ, Dept Med, Nashville, TN USA
基金
加拿大健康研究院;
关键词
isoprostanes; isofurans; oxidative stress; CRP; Inuit; metabolic syndrome; HYPERTRIGLYCERIDEMIC-WAIST PHENOTYPE; OXIDATIVE STRESS; OXIDANT STRESS; METABOLIC-SYNDROME; LIPID-PEROXIDATION; BIOLOGICAL-FLUIDS; CIRCUMPOLAR INUIT; BLOOD-PRESSURE; TISSUE OXYGEN; HEALTH SURVEY;
D O I
10.3109/10715762.2012.702900
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Objectives: The aim of the present study was to investigate the potential importance of oxidative stress, measured by isoprostanes-related compounds, as non-traditional risk factor for cardiovascular disease. We planned to examine the relationship between concentrations of plasma F-2- isoprostanes (F-2-IsoPs), isofurans (IsoFs), measures of obesity and various cardiometabolic risk factors. Materials and methods: Cross-sectional study using a sub-sample from the population of a survey conducted in the summer and fall 2007 and 2008 by Canadian Coastguard Ship Amundsen in 36 Canadian Arctic Inuit communities. Subjects included a subset (n = 233) of a total study population (n = 2595) with a mean age 42.56 +/- 15.39 years and body mass index 27.78 +/- 5.65 kg/m(2). Plasma levels of F-2-IsoPs and IsoFs was determined by gas chromatography/ negative ion chemical ionization/mass spectrometry (GC/NICI/MS) method; and their relationships to waist circumference (WC), blood pressure C reactive proteins (CRP), blood lipids and fasting glucose were assessed by multivariate analyses. Results: Plasma F-2-IsoPs correlated positively with CRP (r = .132, P = .048) and systolic blood pressure (SBP) (r = .157, P = .024) after adjustment for age, sex and body mass index. IsoFs correlated with WC (r = .190, P = .005) and SBP (r = .137, P = .048). F-2-IsoPs were not found elevated in smokers (P = .034), whereas IsoFs were decreased in smokers (P = .001). WC, SBP and sex were found to be major correlates of oxidative stress in Canadian Inuit. Conclusions: Plasma measures of F-2-IsoPs and IsoFs increase with increased obesity and associated cardiometabolic risk factors, including CRP and blood pressure. Simultaneous measurement of IsoFs provides an advantageous mechanistic insight into oxidative stress not captured by F-2-IsoPs alone.
引用
收藏
页码:1258 / 1266
页数:9
相关论文
共 50 条
  • [31] Effects of yoga on cardiovascular disease risk factors: A systematic review and meta-analysis
    Cramer, Holger
    Lauche, Romy
    Haller, Heidemarie
    Steckhan, Nico
    Michalsen, Andreas
    Dobos, Gustav
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 173 (02) : 170 - 183
  • [32] Androgenetic alopecia: Traditional cardiovascular risk factors, metabolic syndrome, and component traits among Nigerian adults
    Oiwoh, S. O.
    Akinboro, A. O.
    Olayemi, O.
    Salawu, A. A.
    Olasode, O. A.
    Onayemi, E. O.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2023, 26 (04) : 463 - 469
  • [33] Traditional and novel cardiovascular risk factors in non-functioning adrenal adenomas
    Yener, Serkan
    Comlekci, Abdurrahman
    Yuksel, Faize
    Sevinc, Ali
    Ertilav, Senem
    Yesil, Sena
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (01) : 83 - 87
  • [34] Elevation of isoprostanes in polycystic ovary syndrome and its relationship with cardiovascular risk factors
    M. Calzada
    N. López
    J. A. Noguera
    J. Mendiola
    A. M. Torres
    Journal of Endocrinological Investigation, 2019, 42 : 75 - 83
  • [35] Prevalence of traditional cardiovascular risk factors among staff of Ladoke Akintola University of Technology, Ogbomoso, Nigeria
    Akintunde, A. A.
    Salawu, A. A.
    Opadijo, O. G.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2014, 17 (06) : 750 - 755
  • [36] Metabolic syndrome and risk factors for cardiovascular disease: are nonagenarians protected?
    Frisard, Madlyn I.
    Rood, Jennifer C.
    Fang, Xiaobing
    Su, Joseph
    Welsh, David A.
    Jazwinski, S. Michal
    Ravussin, Eric
    AGE, 2009, 31 (01) : 67 - 75
  • [37] Metabolic syndrome and risk factors for cardiovascular disease: are nonagenarians protected?
    Madlyn I. Frisard
    Jennifer C. Rood
    Xiaobing Fang
    Joseph Su
    David A. Welsh
    S. Michal Jazwinski
    Eric Ravussin
    AGE, 2009, 31
  • [38] The Correlation of Serum Osteoprotegerin with Non-Traditional Cardiovascular Risk Factors and Arterial Stiffness in Patients with Pre-Dialysis Chronic Kidney Disease: Results from the KNOW-CKD Study
    Chae, Seung Yun
    Chung, WooKyung
    Kim, Yeong Hoon
    Oh, Yun Kyu
    Lee, Joongyub
    Choi, Kyu Hun
    Ahn, Curie
    Kim, Yong-Soo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (53)
  • [39] The Association of Breakfast Frequency and Cardiovascular Disease (CVD) Risk Factors among Adolescents in Malaysia
    Mustafa, Norashikin
    Abd Majid, Hazreen
    Toumpakari, Zoi
    Carroll, Harriet Amy
    Jalaludin, Muhammad Yazid
    Al Sadat, Nabilla
    Johnson, Laura
    NUTRIENTS, 2019, 11 (05)
  • [40] Control of Risk Factors for Cardiovascular Disease among Multinational Patient Population in the Arabian Gulf
    Al-Zakwani, Ibrahim
    Al-Mahmeed, Wael
    Arafah, Mohamed
    Al-Hinai, Ali T.
    Shehab, Abdullah
    Al-Tamimi, Omer
    Al-Awadhi, Mahmoud
    Al-Herz, Shorook
    Al-Anazi, Faisal
    Al-Nemer, Khalid
    Metwally, Othman
    Al-Khadra, Akram
    Fakhry, Mohammed
    Elghetany, Hossam
    Medani, Abdel R.
    Yusufali, Afzal H.
    Al-Jassim, Obaid
    Al-Hallaq, Omar
    Baslaib, Fahad O. A. S.
    Amin, Haitham
    Santos, Raul D.
    Al-Waili, Khalid
    Al-Hashmi, Khamis
    Al-Rasadi, Khalid
    CURRENT VASCULAR PHARMACOLOGY, 2016, 14 (04) : 374 - 381